The Efficacy and Safety of Daptomycin in the Treatment of Gram-positive Bacterial Infection.
Condition(s):AntibioticLast Updated:September 17, 2020Unknown status
Hide Studies Not Open or Pending
Condition(s):AntibioticLast Updated:September 17, 2020Unknown status
Condition(s):Drug Resistance, Multiple; Bacterial Infections; Liver CirrhosisLast Updated:December 7, 2022Active, not recruiting
Condition(s):Bacterial InfectionsLast Updated:December 3, 2021Completed
Condition(s):Severe Bacterial InfectionsLast Updated:March 25, 2021Not yet recruiting
Condition(s):Bacterial Infections; Pneumonia, Pneumocystis Carinii; HIV InfectionsLast Updated:November 4, 2021Completed
Condition(s):Bacterial Infection; Intensive CareLast Updated:August 1, 2018Completed
Condition(s):InfectionLast Updated:May 13, 2019Unknown status
Condition(s):Newborn Sepsis; FeverLast Updated:October 8, 2020Terminated
Condition(s):Pulmonary Disease, Chronic Obstructive (COPD)Last Updated:September 8, 2016Unknown status
Condition(s):Covid19; Acute Respiratory Distress Syndrome; Bacterial Sepsis; Bacterial InfectionsLast Updated:October 12, 2022Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.